![]() |
|
Names | |
---|---|
IUPAC name
N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide
|
|
Identifiers | |
3D model (Jmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.164.363 |
PubChem CID
|
|
UNII | |
|
|
|
|
Properties | |
C7H10N4O4 | |
Molar mass | 214.18 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Etanidazole is a nitroimidazole drug used for its radiosensitizing properties. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase. The result is that tissues become more sensitive to the ionizing radiation used in cancer treatment.